Animal genetic editing is on the rise. The potential to decrease the use of antibiotics and increase animal herd health, has producers attention.
Animal genome editing is beginning to enter the market and has already made its way to other county. U.S. animal groups such as the National Pork Producers Council, in favor of genome editing, are encouraging the reconstruction of regulation.
Currently, the Food and Drug Administration has control over the regulations, with the help of the USDA. Regulations fell to this agency due to animal genome editing used to provide certain types of medical drugs and equipment.
Details of the current regulations under the Guidance for industry (GFI) #187. The GFI draft was revised January 19th, 2017. Under these current regulations, all genetically altered animals are managed as human drugs.
Animal genomic editing has the potential to decrease the use of antibiotics in a herd and increase health herd. Other countries such as Brazil and Argentina are quickly moving ahead with new animal genome editing. That advancement has given their market an advantage edge. To move the U.S. in that direction, the approval process that is extensive, impractical and lengthy would need improvement.
That is why animal groups are asking for the FDA to give up the regulation rights and move all rights to the U.S. Department of Agriculture. The USDA has a review process in place for genetically modified plants that is regulated by Animal and Plant Health Inspection Service (APHIS).